A new in vitro pre-clinical method for testing SARS-CoV-2 nasopharyngeal swabs

一种用于检测SARS-CoV-2鼻咽拭子的新型体外临床前方法

阅读:1

Abstract

The SARS-CoV-2 pandemic underscored the critical role of nasopharyngeal swabbing in virus detection and containment. The urgency for mass production of swabs highlighted the necessity to evaluate their efficiency against the global shortage of medical supplies. Traditional pre-clinical swab testing methods often overlook the complexities of the nasopharyngeal anatomy and mucus properties. This study introduces an innovative in vitro pre-clinical model using a 3D-printed nasopharyngeal cavity lined with a mucus-mimicking SISMA hydrogel, to generate a novel assessment protocol for nasopharyngeal swab efficiency. Reconstructing nasopharyngeal anatomy from CT images, the model used flexible and rigid resins to simulate soft tissue and bone properties. Our evaluation compared the sample collection and release performance of experimental Heicon-type injection-molded swabs and conventional nylon flocked swabs. The Heicon swabs exhibited superior SISMA release efficiency, compared to the standard tubular model. Both swab types demonstrated lower cycle threshold (Ct) values in the tubular model, indicative of higher viral load retrievals. RT-qPCR results confirmed these differences and validated the hydrogel's suitability as a mucosa equivalent. The findings support using our nasopharyngeal model, which better simulates clinical conditions, potentially improving swab design and the reliability of viral detection assays.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。